<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Despite detection on imaging before resection of hepatic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, the natural history of indeterminate pulmonary nodules (<z:chebi fb="1" ids="38218">IPN</z:chebi>) is unknown </plain></SENT>
<SENT sid="1" pm="."><plain>The objective of this study is to determine how often <z:chebi fb="1" ids="38218">IPN</z:chebi> detected on imaging before surgery for hepatic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> represent <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">lung metastases</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Demographics, comorbidities, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> characteristics, and surgical treatments of patients with pre-operative <z:chebi fb="1" ids="38218">IPN</z:chebi> who underwent liver resection and/or radiofrequency ablation for malignant diagnoses were reviewed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: From 2000 to 2010, 90 patients with at least one <z:chebi fb="1" ids="38218">IPN</z:chebi> underwent liver resection or radiofrequency ablation for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Of these, 44 (48.9 %), 32 (35.6 %), and 14 (15.6 %) patients had <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> (CRCLM), primary hepatobiliary <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> (HB), and other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>The median number of <z:chebi fb="1" ids="38218">IPN</z:chebi> was 1 </plain></SENT>
<SENT sid="6" pm="."><plain>The median size was 4 mm </plain></SENT>
<SENT sid="7" pm="."><plain>Twenty (22 %) patients had isolated lung recurrence after hepatic surgical therapy </plain></SENT>
<SENT sid="8" pm="."><plain>Eighty percent occurred in the exact location of the pre-operative <z:chebi fb="1" ids="38218">IPN</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Isolated lung recurrence was more common among patients with CRCLM compared to those with HB and other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (42.9 vs. 9.4 vs. 14.3 %, p = 0.004) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Pre-operatively detected <z:chebi fb="1" ids="38218">IPN</z:chebi> represent <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">lung metastases</z:e> in a substantial portion of patients undergoing surgery for hepatic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="1" ids="38218">IPN</z:chebi> are more likely to represent <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">lung metastases</z:e> in patients with CRCLM compared to those with primary HB and other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>